CE mark for ORTHO Optix™ Reader means lower volume transfusion labs in Europe will now be able to offer results expected of an automated platform.
Ortho Clinical Diagnostics is a global leader in innovative in vitro diagnostic laboratory solutions. The company has now announced the CE Mark availability of its semi-automated ORTHO Optix™ Reader. It says this now completes its Transfusion Medicine portfolio.
When paired with the ORTHO™ Workstation, the ORTHO Optix Reader provides a complete semi-automated testing platform for transfusion labs with low- to mid-volume throughput.
The device has been shown to deliver 99.9% concordance with the fully automated ORTHO VISION® Analyzer. This means it offers larger volume labs and health care networks a way to back-up or scale up their operations without having to invest in an additional full-automation analyzer.
Delivering concordant and high-resolution images means the ORTHO Optix Reader can also help to support the technologist during remote review of results from across the laboratory.
The ORTHO Optix Reader’s high-resolution camera captures color, grayscale, front and back images of each test without operator intervention, which provides objective data for automated results interpretation and eliminates the subjectivity and discrepancies of multiple operators reviewing images by eye.
The ORTHO Optix Reader leverages the same proven ORTHO BioVue® System Column Agglutination Technology as the ORTHO VISION Analyzer and a comprehensive testing menu including antibody panels, selected cells and dilution series.
According to Bob Stowers, Ortho’s head of transfusion medicine product portfolio; “The ORTHO Optix Reader allows transfusion medicine labs with smaller testing volumes the same high-quality, consistent results demonstrated from the award-winning, fully automated ORTHO VISION Analyzer,”
“With the ORTHO Optix Reader now included in Ortho’s comprehensive portfolio of automated and semi-automated solutions, labs of all sizes can customize Ortho’s solutions to optimize their resources without compromising quality and accuracy.”
SOURCE Ortho Clinical Diagnostics. Full release here.